1,3-Dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione

Catalog No. :
ACBONP410
CAS No. :
478-08-0
Molecular Formula :
C15H10O5
Molecular Weight :
270.24

IUPAC Name:1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione

1,3-Dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg98%$72.00Login to see priceInquiryInquiry
10mg98%$108.00Login to see priceInquiryInquiry
25mg98%$183.00Login to see priceInquiryInquiry
50mg98%$274.00Login to see priceInquiryInquiry
100mg98%$405.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,3-Dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione
IUPAC Name1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione
MDL No.MFCD01664482
Molecular FormulaC15H10O5
Molecular Weight270.24
SMILESO=C(C1=CC=CC=C12)C3=CC(O)=C(C(O)=C3C2=O)CO
InChI KeyAMIDUPFSOUCLQB-UHFFFAOYSA-N
SynonymLucidin | 478-08-0 | Henine | 1,3-dihydroxy-2-(hydroxymethyl)anthracene-9,10-dione | Lucidin (quinone) | 1,3-Dihydroxy-2-(hydroxymethyl)anthraquinone | NSC 30546 | CCRIS 1642 | Lucidin (NSC 30546) | NSC-30546 | 60Q5564O9D | 9,10-Anthracenedione, 1,3-dihydroxy-2-(hydroxymethyl)
CAS No.478-08-0
PubChem CID10163

Safety Data

Pictogram
Health hazardHarmful or irritant
Signal Word
Danger
Hazard Statement(s)
H302-H350
Precautionary Statement(s)
P201-P202-P264-P270-P280-P301+P312+P330-P308+P313-P405-P501

Synthetic Route by SureRoute

1. ACBONP410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBONP410 route product structure diagram
    ACBONP410478-08-0
Inquiry

2. ACBONP410 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACBONP410 route product structure diagram
    ACBONP410478-08-0
Inquiry

Comments (0)